Dolby Laboratories Reports Second Quarter Fiscal 2015 Financial Results

Go back to Dolby Laboratories Reports Second Quarter Fiscal 2015 Financial Results

JPMorgan Upgrades Dolby Laboratories (DLB) to Overweight

April 22, 2015 6:45 AM EDT

JPMorgan upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Overweight with a price target of $48.00 (from $39.00). Yesterday Dolby Laboratories reported Q2 earnings results.

For an analyst ratings summary and ratings history on Dolby Laboratories... More

Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance

April 21, 2015 4:25 PM EDT

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.72, $0.08 better than the analyst estimate of $0.64. Revenue for the quarter came in at $271.9 million versus the consensus estimate of $265.46 million.

Dolby Laboratories sees Q3 2015 EPS of $0.43-$0.49, versus the consensus of $0.32. Dolby Laboratories sees Q3 2015... More